IL37224A - Pharmaceutical preparations containing 3 - acyloxypropyl - 2 - trimethyl ammonium (noble phosphates - Google Patents
Pharmaceutical preparations containing 3 - acyloxypropyl - 2 - trimethyl ammonium (noble phosphatesInfo
- Publication number
- IL37224A IL37224A IL37224A IL3722471A IL37224A IL 37224 A IL37224 A IL 37224A IL 37224 A IL37224 A IL 37224A IL 3722471 A IL3722471 A IL 3722471A IL 37224 A IL37224 A IL 37224A
- Authority
- IL
- Israel
- Prior art keywords
- formula
- pharmaceutical compositions
- acyloxypropyl
- trimethylammonium
- compositions containing
- Prior art date
Links
- 229910019142 PO4 Inorganic materials 0.000 title claims description 8
- 239000008194 pharmaceutical composition Substances 0.000 title claims description 6
- 235000021317 phosphate Nutrition 0.000 title description 7
- 239000000203 mixture Substances 0.000 claims description 14
- 239000010452 phosphate Substances 0.000 claims description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 3
- 239000003937 drug carrier Substances 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 239000004480 active ingredient Substances 0.000 description 12
- 239000000243 solution Substances 0.000 description 11
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 10
- 239000003826 tablet Substances 0.000 description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 239000012153 distilled water Substances 0.000 description 6
- TWHXWYVOWJCXSI-UHFFFAOYSA-N phosphoric acid;hydrate Chemical compound O.OP(O)(O)=O TWHXWYVOWJCXSI-UHFFFAOYSA-N 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 241001558496 Talpa caeca Species 0.000 description 5
- -1 ethyl phosphates Chemical class 0.000 description 5
- 235000019359 magnesium stearate Nutrition 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 239000008298 dragée Substances 0.000 description 4
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 4
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 4
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 4
- 229920001592 potato starch Polymers 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 4
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 description 3
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 3
- 229940035437 1,3-propanediol Drugs 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 150000004682 monohydrates Chemical class 0.000 description 3
- 238000007911 parenteral administration Methods 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 229920000166 polytrimethylene carbonate Polymers 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- 239000011975 tartaric acid Substances 0.000 description 3
- 235000002906 tartaric acid Nutrition 0.000 description 3
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 2
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 2
- LEUZGGFIZYRTOY-UHFFFAOYSA-N 3-hydroxypropyl decanoate Chemical compound CCCCCCCCCC(=O)OCCCO LEUZGGFIZYRTOY-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 239000003708 ampul Substances 0.000 description 2
- 239000010617 anise oil Substances 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 229910000389 calcium phosphate Inorganic materials 0.000 description 2
- 235000011010 calcium phosphates Nutrition 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 230000002949 hemolytic effect Effects 0.000 description 2
- 150000004677 hydrates Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229940041616 menthol Drugs 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 2
- 229940081974 saccharin Drugs 0.000 description 2
- 235000019204 saccharin Nutrition 0.000 description 2
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 2
- CQLFBEKRDQMJLZ-UHFFFAOYSA-M silver acetate Chemical compound [Ag+].CC([O-])=O CQLFBEKRDQMJLZ-UHFFFAOYSA-M 0.000 description 2
- 229940071536 silver acetate Drugs 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
- FRUYNPJKMKKZPE-UHFFFAOYSA-N 2-bromoethyl dihydrogen phosphate;dihydrochloride Chemical compound Cl.Cl.OP(O)(=O)OCCBr FRUYNPJKMKKZPE-UHFFFAOYSA-N 0.000 description 1
- 235000003911 Arachis Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- 206010062016 Immunosuppression Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 150000001558 benzoic acid derivatives Chemical class 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- IPIVAXLHTVNRBS-UHFFFAOYSA-N decanoyl chloride Chemical compound CCCCCCCCCC(Cl)=O IPIVAXLHTVNRBS-UHFFFAOYSA-N 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- OVARTBFNCCXQKS-UHFFFAOYSA-N propan-2-one;hydrate Chemical compound O.CC(C)=O OVARTBFNCCXQKS-UHFFFAOYSA-N 0.000 description 1
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical compound CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 239000007940 sugar coated tablet Substances 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- DLYUQMMRRRQYAE-UHFFFAOYSA-N tetraphosphorus decaoxide Chemical compound O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 1
- 229940086542 triethylamine Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2033361A DE2033361C3 (de) | 1970-07-06 | 1970-07-06 | Acylpropandiol-(13)-phosphorsäurecholinester und Verfahren zu deren Herstellung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL37224A0 IL37224A0 (en) | 1971-10-20 |
| IL37224A true IL37224A (en) | 1974-12-31 |
Family
ID=5775903
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL37224A IL37224A (en) | 1970-07-06 | 1971-07-05 | Pharmaceutical preparations containing 3 - acyloxypropyl - 2 - trimethyl ammonium (noble phosphates |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US3694474A (ro) |
| KR (1) | KR780000027B1 (ro) |
| AT (1) | AT300837B (ro) |
| BE (1) | BE769533A (ro) |
| BG (1) | BG17813A3 (ro) |
| CA (1) | CA979918A (ro) |
| DE (1) | DE2033361C3 (ro) |
| ES (1) | ES392735A1 (ro) |
| FR (1) | FR2100867B1 (ro) |
| GB (1) | GB1319402A (ro) |
| HU (1) | HU163186B (ro) |
| IE (1) | IE35441B1 (ro) |
| IL (1) | IL37224A (ro) |
| NL (1) | NL7109243A (ro) |
| NO (1) | NO131988C (ro) |
| PH (1) | PH9282A (ro) |
| RO (1) | RO62390A (ro) |
| SE (1) | SE382062B (ro) |
| SU (1) | SU517261A3 (ro) |
| ZA (1) | ZA714374B (ro) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4163748A (en) * | 1973-09-06 | 1979-08-07 | Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. | Propane-1,3-diol phosphatides and method of preparing the same |
| DE2619686C2 (de) * | 1976-05-04 | 1986-08-07 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen | Verwendung eines Lysolecithins zur Tumorbehandlung |
| US5030733A (en) * | 1987-07-23 | 1991-07-09 | Hoechst-Roussel Pharmaceticals Incorporated | Hydroxy-, alkoxy- and benzyloxy-substituted phospholipids |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3542820A (en) * | 1968-10-08 | 1970-11-24 | American Home Prod | Alpha,omega - alkanediolphosphorylalkanolamine derivatives and process for preparing thereof |
-
1970
- 1970-07-06 DE DE2033361A patent/DE2033361C3/de not_active Expired
-
1971
- 1971-06-17 BG BG017836A patent/BG17813A3/xx unknown
- 1971-06-30 ES ES392735A patent/ES392735A1/es not_active Expired
- 1971-07-02 US US159552A patent/US3694474A/en not_active Expired - Lifetime
- 1971-07-02 SU SU1680403A patent/SU517261A3/ru active
- 1971-07-05 NL NL7109243A patent/NL7109243A/xx not_active Application Discontinuation
- 1971-07-05 SE SE7108672A patent/SE382062B/xx unknown
- 1971-07-05 GB GB3144771A patent/GB1319402A/en not_active Expired
- 1971-07-05 RO RO7100067557A patent/RO62390A/ro unknown
- 1971-07-05 ZA ZA714374A patent/ZA714374B/xx unknown
- 1971-07-05 HU HUTO855A patent/HU163186B/hu unknown
- 1971-07-05 IL IL37224A patent/IL37224A/en unknown
- 1971-07-05 NO NO2557/71A patent/NO131988C/no unknown
- 1971-07-05 BE BE769533A patent/BE769533A/xx unknown
- 1971-07-06 FR FR7124656A patent/FR2100867B1/fr not_active Expired
- 1971-07-06 AT AT584171A patent/AT300837B/de not_active IP Right Cessation
- 1971-07-06 KR KR7100926A patent/KR780000027B1/ko not_active Expired
- 1971-07-06 IE IE865/71A patent/IE35441B1/xx unknown
- 1971-07-06 CA CA117,464A patent/CA979918A/en not_active Expired
- 1971-07-06 PH PH12606*UA patent/PH9282A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IE35441L (en) | 1972-01-06 |
| IL37224A0 (en) | 1971-10-20 |
| CA979918A (en) | 1975-12-16 |
| BG17813A3 (bg) | 1973-12-25 |
| AT300837B (de) | 1972-08-10 |
| US3694474A (en) | 1972-09-26 |
| NO131988B (ro) | 1975-05-26 |
| HU163186B (ro) | 1973-06-28 |
| PH9282A (en) | 1975-08-05 |
| FR2100867A1 (ro) | 1972-03-24 |
| SU517261A3 (ru) | 1976-06-05 |
| DE2033361C3 (de) | 1980-02-21 |
| BE769533A (fr) | 1971-11-16 |
| NO131988C (ro) | 1975-09-03 |
| KR780000027B1 (en) | 1978-03-10 |
| ES392735A1 (es) | 1973-08-01 |
| SE382062B (sv) | 1976-01-12 |
| DE2033361B2 (de) | 1979-06-07 |
| ZA714374B (en) | 1972-04-26 |
| IE35441B1 (en) | 1976-02-18 |
| FR2100867B1 (ro) | 1975-08-01 |
| GB1319402A (en) | 1973-06-06 |
| NL7109243A (ro) | 1972-01-10 |
| DE2033361A1 (de) | 1972-01-20 |
| RO62390A (fr) | 1978-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2528149B2 (ja) | Ｄ―３，４，５―置換―ミオ―イノシト―ル―１，２，６―トリホスフェ―ト | |
| LU87290A1 (fr) | Derives de 4'-phosphates de glucosides d'epipodophyllotoxine | |
| CS216526B2 (en) | Method of making the glycerole esters | |
| CS220790B2 (en) | Method of separation of the -6-methoxy-alpha-methyl-2-naphtalene vinegar acid from the mixtures of the a/-/-6-methoxy-alpha-methyl-2/naphtalene vinegar acid or salts thereof | |
| JP3102798B2 (ja) | イノシトールの誘導体、それを含む製剤及びそれらの使用法 | |
| JPS59501211A (ja) | 燐脂質合成用の新規グリセリン誘導体 | |
| US4006204A (en) | Phosphoric acid diesters | |
| US5155099A (en) | Alkylphosphonoserines and pharmaceutical compositions useful as cytostatic agents | |
| US4163748A (en) | Propane-1,3-diol phosphatides and method of preparing the same | |
| HK217196A (en) | Diamine salts of clavulanic acid | |
| SU648082A3 (ru) | Способ получени производных аминокислот, их солей, рацематов или оптически-активных антиподов | |
| US4387232A (en) | Process for preparing N-acylcarnosine | |
| CA1052810A (en) | .omega.-(N-ACYLAMINO) ALKYLPHOSPHORYL ETHANOLAMINES, PROCESS FOR PREPARING THEM, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USES | |
| IL37224A (en) | Pharmaceutical preparations containing 3 - acyloxypropyl - 2 - trimethyl ammonium (noble phosphates | |
| US4751320A (en) | Phosphoric ester and process for producing same | |
| EP0787135A1 (fr) | Derives hydrosolubles d'epipodophyllotoxine, leur procede de preparation, leur utilisation a titre de medicament, et leur utilisation destinee aux traitements anticancereux | |
| US4745185A (en) | D-arabinose-1,5-diphosphate salts and methods for the treatment of diabetes | |
| US5089492A (en) | Pharmaceuticals and dietetics containing acylamino acid derivatives | |
| US2962499A (en) | Certain esters of tropine and tropinium salts | |
| US5532380A (en) | R,R,S,S-2-nitroimidazole derivatives | |
| CA1068291A (en) | Process for preparing 1,2-diacyl-3-glycerylphosphorylcholines | |
| JPS61129190A (ja) | 重合性グリセロリン脂質 | |
| RU2108336C1 (ru) | Производные фосфолипидов, способ их получения, фармацевтическая композиция и способ ее получения | |
| FI91757C (fi) | Menetelmä terapeuttisesti käyttökelpoisten, /3S(Z)/-2-///1-(2-amino-4-tiatsolyyli)-2-//2,2-dimetyyli-4-okso-1-(sulfo-oksi)-3-atsetidinyyli/amino/-2-oksoetylideeni/amino/oksi/etikkahapon kiteisten dierytromysiini- ja dikoliinisuolojen valmistamiseksi | |
| US3475470A (en) | New amino acid ester complexes |